Skip to main content
Signal8

MANGOCEUTICALS, INC. (MGRX)

Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc.

Sector: Services-Misc Health & Allied Services, NEC

Industry: Medical - Healthcare Information Services

Mangoceuticals, Inc. logo

Mangoceuticals, Inc.

NASDAQ:MGRXHealthcare
-0.19%$0.1600
CLOSED
AH$0.1654+3.38%vs close
Mkt Cap$3.56M
EV-
Float17.27M
O/S22.22M
VOL409K sh
$ Vol$65K
RVOL0.52×
Inst Own7.5%
SI0.3%
Net Cash/Sh-
Dilution
Mangoceuticals, Inc. logoNASDAQ:MGRXClosed$0.1600-0.19%
FormDescription
DEF 14A
Definitive Proxy Statement
10-Q
Quarterly Report
8-K
3.03,5.03,5.07,9.01
1-A
SEC Filing
8-K
5.07,5.08,8.01
PRE 14A
Preliminary Proxy Statement
8-K
424B5
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
13D/A
8-K
8-K
1.02,9.01
10-Q
425
Business Combination Communication
425
Business Combination Communication
425
Business Combination Communication
8-K
8.01,9.01
425
Business Combination Communication
8-K
425
Business Combination Communication
S-8
SEC Filing
8-K
1.01,3.02,9.01
10-Q
Quarterly Report

1-25 of 246

…

Recent SEC filings with analysis

    Mangoceuticals, Inc. (MGRX) SEC Filings: 10-K, 10-Q, 8-K | Signal8